179625-68-4

Upstream product

• 215930-26-0 N-[4-Chloro-3-(2-methyl-quinolin-8-yloxymethyl)-phenyl]-2-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-acetamide 
• 179625-65-1 8-(2-Chloro-5-nitrobenzyloxy)-2-methylquinoline 
• 179625-66-2 4-Chloro-3-(2-methyl-quinolin-8-yloxymethyl)-phenylamine 
• 206884-19-7 Methanesulfonic acid 2-chloro-5-nitro-benzyl ester 
• 80866-80-4 2-chloro-5-nitrobenzyl alcohol 
• 826-81-3 2-methyl-8-quinolinol 
• 179625-67-3 8-[2-Chloro-5-[N-methyl-N-(phthalimidoacetyl)amino]-benzyloxy]-2-methylquinoline 

Relevant academic research and scientific papers

A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 4. Discovery of novel frameworks mimicking the active conformation

In recent articles we reported the identification of a series of 8- [[2,6-dichloro-3-[N-methyl-N-[(E)- (substituted)acryloylglycyl]amino]benzyl]oxy]-2-methylimidazo[1,2- a]pyridines as the first orally active non-peptide bradykinin (BK) B2 rece